Conference abstractPublished 24 Apr 2019
Overt hepatic encephalopathy in cirrhotics listed for liver transplant in the setting of frailty
Baylor University Medical Center USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background & Aim: Hepatic encephalopathy (HE) is a reversible neurocognitive condition that has morbidity and mortality, and is associated with frequent readmissions. With the increased recognition of frailty in decompensated cirrhotics awaiting liver transplantation (LT), risk stratifi cation using frailty as a surrogate marker on the susceptibility of developing overt HE (OHE) in this population has not been well characterized. Th us, we aimed to describe the prevalence and potential association (using frailty as a surrogate marker) of OHE in patients listed for LT. Methods: We evaluated 71 patients listed for LT between October 2015 and May 2018, who demonstrated frailty, using the Liver Frailty Index (LFI) ≥4.5 for stratifi cation. On the same day as LFI testing, HE episodes were determined prospectively from the time of LT listing. Logistic regression assessed associations between frailty and OHE. Th e relationship between frailty, HE and hospital readmission were determined using Fisher’s exact tests. Results: A total of 41/71 (58%) cirrhotic patients received LT; 17 (24%) were delisted, and 13 (18%) patients are currently on the waitlist. Of the 41 LT recipients, the majority were Caucasian (78%) with a mean age of 57.6±9.3 years old, 58% were male, Hepatitis C virus, alcoholic and non-alcoholic liver diseases were the leading etiologies (20%, 20% and 15%), respectively. Th e mean MELD- Na was 18.6 and mean albumin of 3 mg/dl. At the time of LT listing, 34/71 (48%) demonstrated frailty, of which 22/34 (65%) were admitted for OHE compared to 12/34 (35%) without OHE, p=0.23. Overall, more females (11/17; 65%) compared to males (6/23; 26%) demonstrated signifi cantly more OHE episodes (p=0.02) with no diff erences in lactulose+rifaximin therapy observed between the groups. Th e odds of frailty were higher in patients with HE (OR 1.94; 95% CI=0.75-5.0). Among the frail cirrhotics who were delisted, a higher number of patients (40%) demonstrated a prior episode of HE, compared to those without prior HE (24%) which did not reach statistical signifi cance. Conclusion: HE and frailty are commonly seen among cirrhotic patients listed for LT and may contribute to higher delisting rates. Furthermore, frailty may predispose to higher OHE episodes, which may be seen in higher rates in females however larger multicenter studies are needed.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGastroenterology & Hepatology
- SubjectSurgery
- BylineArticles whose byline prints “Robert Rahimi”